You are here: Industry Insights > COVID-19

News List

Some At-Home Tests May Miss Omicron in Early Stages of Infection drugs
January 06, 2022
The Abbott BinaxNOW and Quidel QuickVue -- two widely used rapid at-home COVID-19 tests -- may sometimes fail to spot evidence of the omicron variant in the first days after infection, even when people are carrying substantial levels of the virus, prelimi
Pentarlandir Proves Effective Against COVID-19 Variants in Preclinical Studies contractpharma
January 06, 2022
Costs for the drug are expected to be significantly lower than for Pfizer’s Paxlovid.
PCR not needed following lateral flow test under new guidelines pharmatimes
January 06, 2022
Testing rules for COVID-19 are set to be eased for those who test positive on a lateral flow test but are asymptomatic.
Merck KGaA to Acquire Exelead for $780M contractpharma
January 06, 2022
Enhances the company's experience in producing lipids, one of the critical components for the formulation of mRNA therapeutics including Covid-19 vaccines.
COVID-19 Oral Vaccine and Antibody Booster: B. subtilis Spores, Biotechnology Breakthrough by DreamTec prnasia
January 05, 2022
Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) has its major breakthrough in developing a COVID-19 oral vaccine.
Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization prnewswire
January 05, 2022
Today, the National Comprehensive Cancer Network? (NCCN?) published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of COVID-19 in people with cancer.
With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine prnewswire
January 05, 2022
Thermal Custom Packaging (TCP), a company specializing in transportation solutions for sensitive healthcare and military cargo, is bringing its packaging to the front lines of the COVID vaccine distribution...
Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill ExpressPharma
January 05, 2022
Dr Reddy’s Laboratories will launch its generic version of Merck’s antiviral COVID-19 pill, Molnupiravir, and price it at Rs 35 ($0.4693) per capsule, a company spokesperson said yesterday.
FDA expands EUA of Pfizer-BioNTech’s Covid-19 booster shot to adolescents Pharmaceutical-Technology
January 05, 2022
The US Food and Drug Administration (FDA) has granted an expanded emergency use authorization (EUA) for the Pfizer and BioNTech’s Covid-19 vaccine’s booster dose to adolescents aged 12 years and above.
ImmunityBio and Amyris conclude Covid-19 vaccine commercialisation JV Pharmaceutical-Technology
January 05, 2022
ImmunityBio and Amyris have concluded a joint venture (JV) agreement that was announced earlier to speed up the marketing of a next-generation vaccine for Covid-19.